Sign in

CIK 0001084267 · Non-accelerated filer<br>Smaller reporting company

Mobiquity Technologies, Inc.

Sign in to watch
Tickers
MOBQ MOBQW
Exchange
OTC
Industry
Services-Advertising
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
113427886
Phone
516-256-7766
Business address
35 TORRINGTON LANE, SHOREHAM, NY, 11786
Former names
ACE MARKETING & PROMOTIONS INC

Securities

  • MOBQ Common stock OTC
  • MOBQW Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-08-06 Salkind Gene Director Conversion +7,675,160 $0.20 $1.5M 8,223,695
2024-08-06 Salkind Gene Director Conversion · Series H Preferred Stock −751,973 581,544
2024-08-06 Salkind Gene Director Conversion +7,675,160 $0.20 $1.5M 8,223,695
2024-08-06 Salkind Gene Director Conversion · Series H Preferred Stock −751,973 616,201
2024-07-25 Salkind Gene Director Grant or award · Convertible Promissory Notes +50,000 8,135,931
2024-06-27 Salkind Gene Director Grant or award · Convertible Promissory Notes +160,000 8,035,931
2023-12-19 Trepeta Sean Pres of Mobiquity Networks Grant or award · Common Stock Options +50,000 61,117
2023-12-19 McDonnell Sean CFO Grant or award · Common Stock Options +50,000 51,867
2023-12-19 Bauersfeld Paul Chief Technology Officer Grant or award · Common Stock Options +150,000 161,183
2023-12-19 Julia Dean L. CEO Grant or award · Common Stock Options +950,000 975,817
2023-12-19 Provost Anne Schmidt Director Grant or award · Common stock options +50,000 51,667
2023-12-19 Booker Stuart Byron Director Grant or award · Common stock options +50,000 51,667
2023-12-19 Knight Nate Director Grant or award · Common stock options +50,000 51,667
2023-12-19 Salkind Gene Director Grant or award · Common stock options +100,000 7,715,931
2023-12-15 Salkind Gene Director Grant or award · Preferred Stock Series G −300,789 3,103,990
2023-12-15 Salkind Gene Director Returned to the company · Preferred Stock Series H +751,973 7,615,931
2023-11-07 Salkind Gene Director Option exercise · Common Stock −0 96,100
2023-11-07 Salkind Gene Director Grant or award · Preferred Stock +300,789 3,103,990
2023-10-06 Salkind Gene Director Grant or award +150,000 $0.65 $98K 448,535
2023-10-06 Salkind Gene Director Grant or award · Common Stock +0 524,671

Page 2 of 9 · 170 trades